Update from the PSMA-dRT trial: A randomized phase III trial of PSMA-PET prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer.

被引：0
|
作者：
Nikitas, John
Lam, Ethan C.
Booker, Kiara M.
Fendler, Wolfgang P.
Eiber, Matthias
Hadaschik, Boris A.
Herrmann, Ken
Hirmas, Nader
Lanzafame, Helena
Stuschke, Martin
Czernin, Johannes
Steinberg, Michael L.
Nickols, Nicholas George
Kishan, Amar Upadhyaya
Calais, Jeremie
机构：
[1] Univ Calif Los Angeles, Dept Radiat Oncol, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Los Angeles, CA USA
[3] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Nucl Med, Essen, Germany
[4] Tech Univ Munich, Dept Nucl Med, Munich, Germany
[5] Univ Duisburg Essen, Dept Urol, Essen, Germany
[6] Univ Hosp Essen, German Canc Consortium DKTK, Essen, Germany
[7] Univ Duisburg Essen, Dept Nucl Med, Essen, Germany
[8] Univ Duisburg Essen, Univ Med Essen, Dept Radiotherapy, Essen, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
613-615-646-3281-7408-2399; 261-137; 283-183-180; 613-545; 261-436-2730; 14; 6; 3; 3617; 2;
D O I：
10.1200/JCO.2024.42.4_suppl.291
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：291 / 291
页数：1
相关论文
共 50 条
  • [41] PSMA-PET in high-risk prostate cancer patients suitable for radical treatments: Scenario of detection and clinical impact for staging setting
    Bianchi, L.
    Pissavini, A.
    Droghetti, M.
    Pugliese, M.
    Massimiliano, P.
    Riccardo, S.
    Balestrazzi, E.
    Mei, R.
    Farolfi, A.
    Vetrone, L.
    Serani, F.
    Calderoni, L.
    Stretta, M.
    Morganti, A. G.
    Schiavina, R.
    Castellucci, P.
    Fanti, S.
    Brunocilla, E.
    EUROPEAN UROLOGY, 2023, 83 : S89 - S90
  • [42] Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer
    Zarei, Maryam
    Wallsten, Elin
    Grefve, Josefine
    Soderkvist, Karin
    Gunnlaugsson, Adalsteinn
    Sandgren, Kristina
    Jonsson, Joakim
    Lindberg, Angsana Keeratijarut
    Nilsson, Erik
    Bergh, Anders
    Zackrisson, Bjorn
    Moreau, Mathieu
    Karlsson, Camilla Thellenberg
    Olsson, Lars. E.
    Widmark, Anders
    Riklund, Katrine
    Blomqvist, Lennart
    Loegager, Vibeke Berg
    Axelsson, Jan
    Strandberg, Sara N.
    Nyholm, Tufve
    ACTA ONCOLOGICA, 2024, 63 : 503 - 510
  • [43] Phase II trial of definitive radiotherapy with leuprolide and enzalutamide in high-risk prostate cancer
    de la Calle, Claire Marie
    Chang, Albert
    Rashid, Ghezal
    Wong, Anthony C.
    Choi, Alice
    Feng, Felix Y.
    Gottschalk, Alexander R.
    Menzel, Paul Lawrence
    Carroll, Peter
    Hao Gia Nguyen
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [44] Whole-Pelvic Versus Prostate-Only Radiation Therapy in Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Brachytherapy Boost
    Yang, D. D.
    Mahal, B. A.
    Muralidhar, V.
    Martin, N. E.
    King, M.
    Mouw, K.
    Nguyen, P. L.
    Orio, P. F., III
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E150 - E151
  • [45] PSMA EXPRESSION IN HIGH-RISK PROSTATE CANCER: HEAD-TO-HEAD COMPARISON OF PREOPERATIVE PSMA-PET FEATURES AND IMMUNOHISTOCHEMISTRY ANALYSIS OF BIOPTIC CORES AND WHOLE MOUNT SPECIMEN
    Presutti, Massimiliano
    Droghetti, Matteo
    Bianchi, Lorenzo
    Vetrone, Luigia
    Mei, Riccardo
    Giunchi, Francesca
    Farolfi, Andrea
    Castellucci, Paolo
    Degiovanni, Alessio
    D'Errico, Antonietta
    Schiavina, Riccardo
    Fiorentino, Michelangelo
    Fanti, Stefano
    Brunocilla, Eugenio
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1200 - E1200
  • [46] Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial
    Murthy, Vedang
    Maitre, Priyamvada
    Kannan, Sadhana
    Panigrahi, Gitanjali
    Krishnatry, Rahul
    Bakshi, Ganesh
    Prakash, Gagan
    Pal, Mahendra
    Menon, Santosh
    Phurailatpam, Reena
    Mokal, Smruti
    Chaurasiya, Dipika
    Popat, Palak
    Sable, Nilesh
    Agarwal, Archi
    Rangarajan, Venkatesh
    Joshi, Amit
    Noronha, Vanita
    Prabhash, Kumar
    Mahantshetty, Umesh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (11) : 1234 - +
  • [47] Phase 1 Trial of Neoadjuvant Radiation Therapy Before Prostatectomy for High-Risk Prostate Cancer
    Koontz, Bridget F.
    Quaranta, Brian P.
    Pura, John A.
    Lee, W. R.
    Vujaskovic, Zeljko
    Gerber, Leah
    Haake, Michael
    Anscher, Mitchell S.
    Robertson, Cary N.
    Polascik, Thomas J.
    Moul, Judd W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (01): : 88 - 93
  • [48] A RANDOMIZED PHASE II TRIAL OF PROSTATE BOOST IRRADIATION WITH STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN HIGH-RISK PROSTATE CANCER. THE PBS TRIAL
    Douvi, Georgia
    Isfahanian, Naghmeh
    Lukka, Himanshu
    IanDayes
    Quan, Kimmen
    Schnarr, Kara Lynne
    Goldberg, Mira
    Wright, Jim
    Hallock, Abhirami
    Ishkanian, Adrian
    Cuthbert, David
    Swaminath, Anand
    Chow, Tom
    Diamond, Kevin
    Cutz, Jean-Claude
    Kavsak, Peter
    Thabane, Lehana
    Tsakiridis, Theodoros
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S87 - S88
  • [49] Gallium 68 PSMA-11 PET/MR Imaging in Patients with Intermediate- or High-Risk Prostate Cancer
    Park, Sonya Youngju
    Zacharias, Claudia
    Harrison, Caitlyn
    Fan, Richard E.
    Kunder, Christian
    Hatami, Negin
    Giesel, Frederik
    Ghanouni, Pejman
    Daniel, Bruce
    Loening, Andreas M.
    Sonn, Geoffrey A.
    Iagaru, Andrei
    RADIOLOGY, 2018, 288 (02) : 495 - 505
  • [50] Baseline PSMA-PET/CT as a predictor of PSA persistence following radical prostatectomy in high-risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy
    Du, Xinxing
    Dong, Yanhao
    Liu, Jiazhou
    Su, Yun
    Zhu, Yinjie
    Pan, Jiahua
    Dong, Baijun
    Chen, Ruohua
    Liu, Jianjun
    Tong, Zhen
    Pienta, Kenneth J.
    Rowe, Steven P.
    Dong, Liang
    Xue, Wei
    PROSTATE, 2023, 83 (11): : 1112 - 1120
12345